Search

Author/Creator Edwards, C.

61. Postpartum-specific Vital Sign Reference Ranges. Issue 1 (23rd March 2022)

Authors:
Green, L.J.; Pullon, R.; Mackillop, L.H.; Gerry, S.; Birks, J.; Salvi, D.; Davidson, S.; Loerup, L.; Tarassenko, L.; Mossop, J.; Edwards, C.; Gauntlett, R.; Harding, K.; Chappell, L.C.; Knight, M.; Watkinson, P.J.
Journal:
Obstetric anesthesia digest
Issue:
Volume 42:Issue 1(2022)
Page Start:
14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

63. Postpartum-specific Vital Sign Reference Ranges. Issue 4 (22nd December 2021)

Authors:
Green, L.J.; Pullon, R.; Mackillop, L.H.; Gerry, S.; Birks, J.; Salvi, D.; Davidson, S.; Loerup, L.; Tarassenko, L.; Mossop, J.; Edwards, C.; Gauntlett, R.; Harding, K.; Chappell, L.C.; Knight, M.; Watkinson, P.J.
Journal:
Obstetric anesthesia digest
Issue:
Volume 41:Issue 4(2021)
Page Start:
175
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

67. Randomized trial of a dual‐hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor‐augmented pump therapy. Issue 11 (15th August 2016)

Authors:
Jacobs, P. G.; El Youssef, J.; Reddy, R.; Resalat, N.; Branigan, D.; Condon, J.; Preiser, N.; Ramsey, K.; Jones, M.; Edwards, C.; Kuehl, K.; Leitschuh, J.; Rajhbeharrysingh, U.; Castle, J.R.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 18:Issue 11(2016)
Page Start:
1110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

69. SAT0377 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial. (10th June 2014)

Authors:
Adebajo, A.; Wells, A.; Edwards, C.; Kivitz, A.; Bird, P.; Shah, K.; Hu, C.; Stevens, R.; Aelion, J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
730
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

70. SAT0382 Palace 4, A Phase 3, Randomized, Controlled TRIAL of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Treatment of Psoriatic Arthritis: Long-Term (52-WEEK) Improvements in Physical Function. (10th June 2014)

Authors:
Wells, A.; Edwards, C.; Adebajo, A.O.; Kivitz, A.J.; Bird, P.; Shah, K.; Hu, C.; Stevens, R.M.; Aelion, J.A.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
732
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗